MedTrace Logo

iTBS rTMS in Mild Cognitive Impairment

NCT05327257 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-01-12

No results posted yet for this study

Summary

The purposes of this research are to test whether it is feasible to administer a treatment protocol called intermittent theta burst stimulation (iTBS) repetitive transcranial magnetic stimulation (rTMS) in adults with mild cognitive impairment (MCI), and to test whether iTBS rTMS treatments can improve memory in mild cognitive impairment (MCI).

Conditions

Interventions

DEVICE

iTBS rTMS

Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)

Sponsors & Collaborators

  • Maria I. Lapid, M.D.

    lead OTHER

Principal Investigators

  • Maria I Lapid · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-11
Primary Completion
2025-12-01
Completion
2025-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05327257 on ClinicalTrials.gov